| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |